Week of January 31st 2022 | Vol. 11, Issue 5
In This Issue
Upcoming Events
Industry M&A Activity
Recent Transactions
Trading Comps
Market Reports
M&A Pipeline
Featured Headlines
Tanner Updates

Quick Links

Contact Information
Managing Director
Business Development

Managing Director
Head of M&A and Capital Advisory
Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to download complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners
March 21-24, 2022 - New York City, NY

October 2022- Charlotte, NC
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
M&A TRANSACTIONS
Pharma & Biotech
13 transactions totaling $3,245 million

Supplies, Equipment & Services
20 transactions totaling $21 million

Healthcare IT & Managed Care
8 transactions totaling $97 million

Healthcare Facilities & Distributors
8 transactions totaling $153 million
PRIVATE PLACEMENTS
Pharma & Biotech
42 transactions totaling $1,200 million

Supplies, Equipment & Services
33 transactions totaling $853 million

Healthcare IT & Managed Care
16 transactions totaling $731 million

Healthcare Facilities & Distributors
3 transactions totaling $44 million
PUBLIC OFFERINGS
Pharma & Biotech
11 transactions totaling $1,498 million

Supplies, Equipment & Services
1 transactions totaling $1 million

Healthcare IT & Managed Care
1 transaction totaling $25 million

Healthcare Facilities & Distributors
0 transactions
TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
MARKET REPORTS
Insight Into Healthcare Related Industries
M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities
Project Alamo
Sell-side | CMO | Corporate Carve out - private label and OTC manufacturing business

Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
FEATURED HEADLINES
A Sampling of Industry Headlines From Last Week
Clarify Health, a healthcare and life sciences platform analytics company, has launched its Clarify Trials software designed to improve the recruitment of clinical trial participants from underserved communities.

The cloud software uses more than 400 social determinants of health (SDoH) to help research sites and investigators expand the diversity of patients enrolled in their trials. SDoH’s take in to account things like where people live, work, their education and numerous other factors that impact health, quality-of-life risks and health outcomes.

The COVID-19 pandemic has helped the push to include more diversity in clinical trials and improve health outcomes in rural, urban and suburban communities traditionally left behind. To further the effort, the FDA released guidance in 2020 to enhance diversity in clinical trials.
In one of the more apt examples of bringing medtech into the home and meeting patients on their terms, the developer of a smart toilet seat has raised $30 million to pursue an FDA clearance.
What if the information you need to gauge your risk of a heart attack within the next year could be found in your eyes? Researchers led by the University of Leeds believe that to be true, and they’ve trained an artificial intelligence program to spot the warning signs.
Less than two years after scoring its first FDA clearance, Akili Interactive is betting big on its digital therapeutic technology. The Massachusetts-based company has signed a reverse-merger deal with Social Capital Suvretta Holdings Corp. I to make its own public debut.
After receiving a European approval for its laparoscopic surgery robot at the end of 2020, Distalmotion has raised $90 million to help take its system to the U.S.

The Medicine Maker features Banks Bourne, Founder and CEO of Tanner Pharma Group, as he discusses how companies can reimagine and strengthen their supply chains when presented with unique challenges.

Over the last 3 months our friends at MAP International have distributed 16,000+ units of Tanner and PAI donated products to support children in 7 countries around the world. Learn more about this collaboration here.